GDTC
CytoMed Therapeutics Limited Ordinary Shares
NASDAQ: GDTC · HEALTHCARE · BIOTECHNOLOGY
$1.00
+0.71% today
Updated 2026-04-30
Market cap
$11.60M
P/E ratio
—
P/S ratio
13.47x
EPS (TTM)
$-0.27
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
CytoMed Therapeutics Limited Ordinary Shares (GDTC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-375.0%
Most recent quarter
When is the next earnings report?
Reporting date
December 31, 2024
Consensus EPS estimate
$-0.04
Fiscal period ending
2024-12-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.0%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
+0.0%
2025-10-02
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-10-02 | $-0.19 | -375.0% | $2.01 | $2.01 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.04 | $-0.19 | -375.0% | — | — |
| 2025-03-31 | $-0.04 | $-0.12 | -200.0% | $100043.00 | +20.4% |
| 2024-12-31 | $-0.04 | — | — | — | — |
| 2024-09-30 | $-0.04 | $-0.04 | +0.0% | $108617.00 | +32.9% |
| 2024-06-30 | $-0.04 | $-0.09 | -125.0% | $82667.00 | -21.3% |
| 2024-03-31 | $-0.04 | $-0.04 | +0.0% | $83106.00 | -22.2% |
| 2023-12-31 | $-0.05 | $-0.05 | +0.0% | — | — |
| 2023-09-30 | $-0.06 | $-0.08 | -33.3% | $81747.00 | — |
| 2023-06-30 | $-0.06 | $-0.06 | +0.0% | $105084.00 | — |
| 2023-03-31 | $-0.06 | $-0.06 | +0.0% | $106785.00 | — |
Frequently asked questions
When does CytoMed Therapeutics Limited Ordinary Shares report next earnings?
CytoMed Therapeutics Limited Ordinary Shares (GDTC) is scheduled to report earnings on December 31, 2024. The consensus EPS estimate is $-0.04.
Has CytoMed Therapeutics Limited Ordinary Shares beaten earnings estimates?
CytoMed Therapeutics Limited Ordinary Shares has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports.
How does GDTC stock react to earnings?
GDTC stock has moved an average of +0.0% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.